Neupulse at TicFest

Exciting times ahead! We're thrilled to announce that Neupulse will be participating in the upcoming TicFest on the 3^rd of December, an inspiring event organised by Tourettes Action, dedicated to supporting individuals and families living with Tourette Syndrome (TS). We are delighted to share that the event is now fully booked reflecting the incredible enthusiasm and support within the TS community.

Our CEO, Paul Cable and Chief Research Officer, Dr Barbara Morera will be attending this special gathering bringing with them a prototype of our groundbreaking medical device designed for the management of tics. Please note that the device will be used only for demonstration purposes and will not be functional at the event.

During the event we will present a short session detailing the Neupulse story from our early research days to the exciting road toward bringing our device to people who need it. This talk will cover the development stages of our medical device, emphasizing the unique challenges and triumphs we've encountered along the way. Most importantly we're excited to share the promising results from our clinical trial completed earlier this year, which marks a significant advancement in Tourette's treatments.

Our presence at TicFest aligns perfectly with our mission to engage with the TS community, gain valuable insights and contribute to a supportive environment for individuals living with this condition. We believe that sharing our journey and the clinical trial outcomes will not only showcase our commitment to innovative healthcare solutions but also offer hope and encouragement to those impacted by TS.

For those who have secured a ticket we look forward to seeing you there!